ATE458739T1 - Zweiphasiges verfahren zur synthese ausgewählter pyrazolopyrimidine - Google Patents
Zweiphasiges verfahren zur synthese ausgewählter pyrazolopyrimidineInfo
- Publication number
- ATE458739T1 ATE458739T1 AT04812693T AT04812693T ATE458739T1 AT E458739 T1 ATE458739 T1 AT E458739T1 AT 04812693 T AT04812693 T AT 04812693T AT 04812693 T AT04812693 T AT 04812693T AT E458739 T1 ATE458739 T1 AT E458739T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrazolopyrimidines
- substituted
- pyrimidin
- phenyl
- salt
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- APXRHPDHORGIEB-UHFFFAOYSA-N 1H-pyrazolo[4,3-d]pyrimidine Chemical class N1=CN=C2C=NNC2=C1 APXRHPDHORGIEB-UHFFFAOYSA-N 0.000 abstract 1
- CBIAWPMZSFFRGN-UHFFFAOYSA-N Indiplon Chemical compound CC(=O)N(C)C1=CC=CC(C=2N3N=CC(=C3N=CC=2)C(=O)C=2SC=CC=2)=C1 CBIAWPMZSFFRGN-UHFFFAOYSA-N 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- -1 aminopyrazole compound Chemical class 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- OGEBRHQLRGFBNV-RZDIXWSQSA-N chembl2036808 Chemical class C12=NC(NCCCC)=NC=C2C(C=2C=CC(F)=CC=2)=NN1C[C@H]1CC[C@H](N)CC1 OGEBRHQLRGFBNV-RZDIXWSQSA-N 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000012429 reaction media Substances 0.000 abstract 1
- HUNXMJYCHXQEGX-UHFFFAOYSA-N zaleplon Chemical compound CCN(C(C)=O)C1=CC=CC(C=2N3N=CC(=C3N=CC=2)C#N)=C1 HUNXMJYCHXQEGX-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53630204P | 2004-01-14 | 2004-01-14 | |
| PCT/US2004/040241 WO2005070931A1 (en) | 2004-01-14 | 2004-12-02 | Two-phase method for the synthesis of selected pyrazolopyrimidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE458739T1 true ATE458739T1 (de) | 2010-03-15 |
Family
ID=34806998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04812693T ATE458739T1 (de) | 2004-01-14 | 2004-12-02 | Zweiphasiges verfahren zur synthese ausgewählter pyrazolopyrimidine |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7498434B2 (de) |
| EP (1) | EP1713808B1 (de) |
| JP (1) | JP2007517876A (de) |
| CN (1) | CN1906197A (de) |
| AT (1) | ATE458739T1 (de) |
| AU (1) | AU2004314335A1 (de) |
| CA (1) | CA2553465A1 (de) |
| DE (1) | DE602004025747D1 (de) |
| ES (1) | ES2338659T3 (de) |
| WO (1) | WO2005070931A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005099712A2 (en) * | 2004-04-19 | 2005-10-27 | Sanmar Speciality Chemicals Limited | Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide |
| WO2006070244A2 (en) * | 2004-11-22 | 2006-07-06 | Bakulesh Mafatlal Khamar | A process for the preparation of zaleplon |
| CN102816163A (zh) * | 2012-08-20 | 2012-12-12 | 四川禾邦阳光制药股份有限公司 | 扎来普隆的新晶型及制备方法 |
| AU2021363703A1 (en) | 2020-10-23 | 2023-06-22 | S2Cbio Inc. | Cftr modulator compounds, compositions, and uses thereof |
| CN112939987B (zh) * | 2021-02-18 | 2022-03-22 | 新乡医学院 | 一种茚地普隆中间体的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4626538A (en) * | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
| US5714607A (en) * | 1995-12-01 | 1998-02-03 | American Cyanamid Company | Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
| US6472528B1 (en) | 1999-08-10 | 2002-10-29 | Neurocrine Biosciences, Inc. | Synthesis of substituted pyrazolopyrimidines |
| US6399621B1 (en) * | 1999-08-10 | 2002-06-04 | American Cyanamid Company | N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| AR029780A1 (es) * | 2000-12-13 | 2003-07-16 | Gador Sa | Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida |
| DE02778962T1 (de) * | 2001-06-12 | 2005-02-10 | Biogal Gyogyszergyar Rt. | VERFAHREN ZUR HERSTELLUNG VON N ç3 (3 CYANOPYRAZOLOç1,5 A!PYRIMIDIN 7 YL)PHENYL!-N-ETHYLACETAMID (ZALEPLON) |
| PL374176A1 (en) * | 2001-08-01 | 2005-10-03 | Biogal Gyogyszergyar Rt | Process for purifying n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process |
-
2004
- 2004-12-02 US US10/585,006 patent/US7498434B2/en not_active Expired - Fee Related
- 2004-12-02 ES ES04812693T patent/ES2338659T3/es not_active Expired - Lifetime
- 2004-12-02 DE DE602004025747T patent/DE602004025747D1/de not_active Expired - Lifetime
- 2004-12-02 CN CNA2004800404724A patent/CN1906197A/zh active Pending
- 2004-12-02 EP EP04812693A patent/EP1713808B1/de not_active Expired - Lifetime
- 2004-12-02 AT AT04812693T patent/ATE458739T1/de not_active IP Right Cessation
- 2004-12-02 JP JP2006549260A patent/JP2007517876A/ja not_active Withdrawn
- 2004-12-02 WO PCT/US2004/040241 patent/WO2005070931A1/en not_active Ceased
- 2004-12-02 AU AU2004314335A patent/AU2004314335A1/en not_active Abandoned
- 2004-12-02 CA CA002553465A patent/CA2553465A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005070931A1 (en) | 2005-08-04 |
| DE602004025747D1 (de) | 2010-04-08 |
| EP1713808B1 (de) | 2010-02-24 |
| AU2004314335A1 (en) | 2005-08-04 |
| CN1906197A (zh) | 2007-01-31 |
| JP2007517876A (ja) | 2007-07-05 |
| US7498434B2 (en) | 2009-03-03 |
| CA2553465A1 (en) | 2005-08-04 |
| US20070155995A1 (en) | 2007-07-05 |
| EP1713808A1 (de) | 2006-10-25 |
| ES2338659T3 (es) | 2010-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2191647A1 (en) | Process improvement in the synthesis of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide | |
| CA2493359A1 (en) | Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto | |
| HRP20070534T3 (en) | Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor | |
| SG170783A1 (en) | Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis | |
| IL190398A0 (en) | Imidazo benzodiazepine derivatives | |
| WO2001062760A3 (en) | A NOVEL CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR | |
| ATE458739T1 (de) | Zweiphasiges verfahren zur synthese ausgewählter pyrazolopyrimidine | |
| WO2002100828A3 (en) | Process for the production of zaleplon | |
| DE60019350D1 (de) | Synthese substituierter Pyrazolopyrimidine | |
| PL374176A1 (en) | Process for purifying n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process | |
| ES8505958A1 (es) | Procedimiento para preparar pirazol (1,5-a)pirimidin-metanonas | |
| WO2005103052A8 (en) | Pyrazolo [1,5-a] pyrimidin-7-one compounds and uses thereof | |
| DE69930416D1 (de) | Cgmp pde5 inhibitoren zur inhalationsbehandlung von sexueller dysfunktion | |
| CA2417875A1 (en) | Polymorphs of zaleplon and methods for the preparation thereof | |
| Petek et al. | 2-Acyl-1-aryl-6, 7-dihydro-1H, 5H-pyrazolo [1, 2-a] pyrazole derivatives: Versatile fluorescent probes with remarkably large Stokes shift | |
| Rahmati | One-pot synthesis of 2-alkyl-7-amino-5-aryl-pyrazolo [1, 5-a] pyrimidine-6-carbonitriles via a domino three-component condensation-oxidation reaction | |
| DE60309159D1 (de) | Verfahren zur herstellung von zaleplon | |
| PT2081935T (pt) | Polimorfo b de n-{2-fluoro-5-3-(tiofeno-2-carbonil)- pirazolo[1,5-a] pirimidin-7-il]-fenil}-n-metil-acetamida | |
| ATE368667T1 (de) | Verfahren zur herstellung von n-ethyl-n-(3-(3- cyanopyrazolo-(1,5-a)-pyrimidin-7-yl)phenyl)- acetamid | |
| WO2005099712A3 (en) | Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide | |
| WO2006070244A3 (en) | A process for the preparation of zaleplon | |
| WO2006127574A3 (en) | Method for the treatment of noise phobia in companion animals | |
| EP1344768B1 (de) | Synthese substituierter Pyrazolopyrimidine | |
| WO2008068600A3 (en) | An improved process for the preparation of zaleplo | |
| CA2550874A1 (en) | Process for the preparation of triazolopyrimidines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |